These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30773006)

  • 1. Adverse Effects of Fine-Particle Exposure on Joints and Their Surrounding Cells and Microenvironment.
    Zhang S; Ren Q; Qi H; Liu S; Liu Y
    ACS Nano; 2019 Mar; 13(3):2729-2748. PubMed ID: 30773006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of concentrated ambient particles on normal and hypersecretory airways in rats.
    Harkema JR; Keeler G; Wagner J; Morishita M; Timm E; Hotchkiss J; Marsik F; Dvonch T; Kaminski N; Barr E
    Res Rep Health Eff Inst; 2004 Aug; (120):1-68; discussion 69-79. PubMed ID: 15543855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons from air pollution epidemiology for studies of engineered nanomaterials.
    Peters A; Rückerl R; Cyrys J
    J Occup Environ Med; 2011 Jun; 53(6 Suppl):S8-S13. PubMed ID: 21654423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fine, ultrafine and nano- particles in the living and working setting: potential health effects and measurement of inhalation exposure].
    Marconi A
    G Ital Med Lav Ergon; 2006; 28(3):258-65. PubMed ID: 17144413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research on advance of health effects of nanoparticles on air pollution in China].
    Xiong L; Wu T; Tang M
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Sep; 49(9):835-9. PubMed ID: 26733144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against fine particle-induced pulmonary and systemic inflammation by omega-3 polyunsaturated fatty acids.
    Li XY; Hao L; Liu YH; Chen CY; Pai VJ; Kang JX
    Biochim Biophys Acta Gen Subj; 2017 Mar; 1861(3):577-584. PubMed ID: 28011301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles.
    Sayes CM; Reed KL; Warheit DB
    Toxicol Sci; 2007 May; 97(1):163-80. PubMed ID: 17301066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered nanoparticle respiratory exposure and potential risks for cardiovascular toxicity: predictive tests and biomarkers.
    Simeonova PP; Erdely A
    Inhal Toxicol; 2009 Jul; 21 Suppl 1():68-73. PubMed ID: 19558236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrafine particle-lung interactions: does size matter?
    Kreyling WG; Semmler-Behnke M; Möller W
    J Aerosol Med; 2006; 19(1):74-83. PubMed ID: 16551218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles.
    Oberdorster G
    Inhal Toxicol; 1996; 8 Suppl():73-89. PubMed ID: 11542496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Airborne particulate matter and human health: toxicological assessment and importance of size and composition of particles for oxidative damage and carcinogenic mechanisms.
    Valavanidis A; Fiotakis K; Vlachogianni T
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2008; 26(4):339-62. PubMed ID: 19034792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Air pollution, ultrafine and nanoparticle toxicology: cellular and molecular interactions.
    Stone V; Johnston H; Clift MJ
    IEEE Trans Nanobioscience; 2007 Dec; 6(4):331-40. PubMed ID: 18217626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoscale and fine zinc oxide particles: can in vitro assays accurately forecast lung hazards following inhalation exposures?
    Warheit DB; Sayes CM; Reed KL
    Environ Sci Technol; 2009 Oct; 43(20):7939-45. PubMed ID: 19921917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk assessment strategies for nanoscale and fine-sized titanium dioxide particles: Recognizing hazard and exposure issues.
    Warheit DB; Donner EM
    Food Chem Toxicol; 2015 Nov; 85():138-47. PubMed ID: 26362081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advances on the biological effect indices for fine particles (PM2.5) in air].
    Zhang W; Cui J; Qi Q
    Wei Sheng Yan Jiu; 2001 Nov; 30(6):379-82. PubMed ID: 12561628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary particulate matter and systemic microvascular dysfunction.
    Nurkiewicz TR; Porter DW; Hubbs AF; Stone S; Moseley AM; Cumpston JL; Goodwill AG; Frisbee SJ; Perrotta PL; Brock RW; Frisbee JC; Boegehold MA; Frazer DG; Chen BT; Castranova V;
    Res Rep Health Eff Inst; 2011 Dec; (164):3-48. PubMed ID: 22329339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric adjustments for interspecies extrapolation of inhaled poorly soluble particles (PSP).
    Jarabek AM; Asgharian B; Miller FJ
    Inhal Toxicol; 2005; 17(7-8):317-34. PubMed ID: 16020031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxides and macrophages in the toxicity of fine particulate matter in rats.
    Laskin DL; Morio L; Hooper K; Li TH; Buckley B; Turpin B
    Res Rep Health Eff Inst; 2003 Dec; (117):1-51; discussion 53-63. PubMed ID: 15035594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary effects of inhaled ultrafine particles.
    Oberdörster G
    Int Arch Occup Environ Health; 2001 Jan; 74(1):1-8. PubMed ID: 11196075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetry and toxicology of inhaled ultrafine particles.
    Schmid O; Möller W; Semmler-Behnke M; Ferron GA; Karg E; Lipka J; Schulz H; Kreyling WG; Stoeger T
    Biomarkers; 2009 Jul; 14 Suppl 1():67-73. PubMed ID: 19604063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.